Search research articles
Contact Us
Filters
Showing results (51-60 of 56) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 56 results.
Asian Journal of Andrology
|
December 4, 2008
Identification of new genetic risk factors for prostate cancer
Michelle Guy, Zsofia Kote-Jarai, Graham G Giles, et al.
The Lancet. Oncology
|
May 4, 2023
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol
Gerhardt Attard, Laura Murphy, Noel W Clarke, et al.
Nature Genetics
|
September 22, 2009
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study
Rosalind A Eeles, Zsofia Kote-Jarai, Ali Amin Al Olama, et al.
Nature Genetics
|
July 12, 2011
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
Zsofia Kote-Jarai, Ali Amin Al Olama, Graham G Giles, et al.
Human Molecular Genetics
|
October 16, 2012
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease
Ali Amin Al Olama, Zsofia Kote-Jarai, Fredrick R Schumacher, et al.
Nature Genetics
|
March 29, 2013
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
Rosalind A Eeles, Ali Amin Al Olama, Sara Benlloch, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 56) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 56 results.
Asian Journal of Andrology
|
December 4, 2008
Identification of new genetic risk factors for prostate cancer
Michelle Guy, Zsofia Kote-Jarai, Graham G Giles, et al.
The Lancet. Oncology
|
May 4, 2023
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol
Gerhardt Attard, Laura Murphy, Noel W Clarke, et al.
Nature Genetics
|
September 22, 2009
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study
Rosalind A Eeles, Zsofia Kote-Jarai, Ali Amin Al Olama, et al.
Nature Genetics
|
July 12, 2011
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
Zsofia Kote-Jarai, Ali Amin Al Olama, Graham G Giles, et al.
Human Molecular Genetics
|
October 16, 2012
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease
Ali Amin Al Olama, Zsofia Kote-Jarai, Fredrick R Schumacher, et al.
Nature Genetics
|
March 29, 2013
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
Rosalind A Eeles, Ali Amin Al Olama, Sara Benlloch, et al.
Page
of 6